Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5374-29-8

Post Buying Request

5374-29-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5374-29-8 Usage

General Description

(2Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)ACETIC ACID is a chemical compound with the molecular formula C6H5NO4S. It is a thiazolidin-4-one derivative, which is a class of compounds known for their diverse pharmacological activities. (2Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)ACETIC ACID has been studied for its potential anti-inflammatory, antioxidant, and antimicrobial properties. It is also being investigated for its potential use in pharmaceuticals and as a precursor in organic synthesis. Overall, (2Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)ACETIC ACID has potential applications in various fields, making it an interesting area of research for its potential medicinal and industrial uses.

Check Digit Verification of cas no

The CAS Registry Mumber 5374-29-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,3,7 and 4 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 5374-29:
(6*5)+(5*3)+(4*7)+(3*4)+(2*2)+(1*9)=98
98 % 10 = 8
So 5374-29-8 is a valid CAS Registry Number.
InChI:InChI=1/C5H3NO4S/c7-3(8)1-2-4(9)6-5(10)11-2/h1H,(H,7,8)(H,6,9,10)/b2-1-

5374-29-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (CBR00426)  (2Z)-(2,4-Dioxo-1,3-thiazolidin-5-ylidene)acetic acid  AldrichCPR

  • 5374-29-8

  • CBR00426-1G

  • 1,611.09CNY

  • Detail

5374-29-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (2Z)-(2,4-Dioxo-1,3-thiazolidin-5-ylidene)acetic acid

1.2 Other means of identification

Product number -
Other names (2Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)ACETIC ACID 95%

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5374-29-8 SDS

5374-29-8Relevant articles and documents

Synthesis and in vitro antiproliferative and antibacterial activity of new thiazolidine-2,4-dione derivatives

Trotsko, Nazar,Przekora, Agata,Zalewska, Justyna,Ginalska, Gra?yna,Paneth, Agata,Wujec, Monika

, p. 17 - 24 (2017/11/14)

In our present research, we synthesised new thiazolidine-2,4-diones (12–28). All the newly synthesised compounds were evaluated for antiproliferative and antibacterial activity. Antiproliferative evaluation was carried out using normal human skin fibroblasts and tumour cell lines: A549, HepG2, and MCF-7. The IC50 values were determined for tested compounds revealing antiproliferative activity. Moreover, safety index (SI) was calculated. Among all tested derivatives, the compound 18 revealed the highest antiproliferative activity against human lung, breast, and liver cancer cells. More importantly, the derivative 18 showed meaningfully lower IC50 values when compared to the reference substance, irinotecan, and relatively high SI values. Moreover, newly synthesised compounds were screened for the bacteria growth inhibition in vitro. According to our screening results, most active compound was the derivative 18 against Gram-positive bacteria. Therefore, it may be implied that the novel compound 18 appears to be a very promising agent for anticancer treatment.

Synthesis and in vitro anticancer activity of 2,4-azolidinedione-acetic acids derivatives

Kaminskyy, Danylo,Zimenkovsky, Borys,Lesyk, Roman

scheme or table, p. 3627 - 3636 (2009/12/04)

The synthesis and evaluation of anticancer activity of 2,4-thia(imida)zolidinedione-3- and 5-acetic acids amides were described. The structures of compounds were determined by IR, 1H NMR, and MS analysis. In vitro anticancer activity of these compounds has been tested in National Cancer Institute (NCI) and the relationships between structure and anticancer activity are discussed. Among 2,4-azolidinedione-acetic acids derivatives 2-[5-(4-chlorobenzylidene)-2,4-dioxo-imidazolidin-3-yl]-N-(2-trifluoromethyl-phenyl)-acetamide (Ic) was superior to other related compounds in terms of high selectivity for the leukemia CCRF-CEM (log GI50 = -6.06), HL-60(TB) (log GI50 = -6.53), MOLT-4 (log GI50 = -6.52) and SR (log GI50 = -6.51) cell lines.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5374-29-8